Patient Engagement

Patient-Researchers and Physician-Consultants Confront Chronic Disease

Article · January 20, 2017

I consider myself a digital health native.

For most of the past 30 years, I’ve been using digital tools and data-generating devices to make daily, often hourly, decisions about how much of a potentially fatal drug I should administer. That drug, insulin, keeps me alive. But get the dosage wrong by even the smallest of amounts, and there are very real and immediate consequences. Best-case scenario: You might tank your afternoon meeting or do poorly on that big algebra test. Worst-case scenario: you’re dead or disabled — an all-too-frequent occurrence among those of us with Type 1 diabetes.

Because of the demands of managing insulin, the role of my physicians has changed dramatically. Once, they were the source of all knowledge and guidance. Now, I consider my physicians to be consultants. They play a critical role in enabling me to manage my diabetes. But, like it or not, I am the executive in charge of maintaining my health and managing my disease.

The responsibility for dosing my insulin rests on me, because it must. Neither my doctor nor I have much choice in the matter. The “same dose every day” insulin regimen is largely — and fortunately — a thing of the past. Most of us who use insulin to stay alive make the decision many times a day about how much we need and when, based on our own measurements, understanding, and experience of life with the disease. Our doctors give us guidance, and we may go to diabetes educators to receive training and advice. But the day-in, day-out decisions are all on us, the diabetes patients.

Anybody reading this who knows anything about type 1 diabetes shouldn’t be surprised. Since the introduction of home glucose meters in 1983, responsible physicians have encouraged and empowered patients to accept and embrace this reality. As personal use devices have become more sophisticated and insulin has improved, this trend has escalated, and many patients are living safer, longer, less restrained lives as a result.

For me, though, disease management doesn’t stop with insulin. After decades of life with difficult-to-control diabetes, I have an array of complications — eye, kidney, and nerve disease — as well as a few common comorbid conditions to help make things more interesting. To manage this, I take 14 different medications. To help keep these medications appropriately tuned, I use an array of other devices in addition to my diabetes devices that provide critical data about everything from blood pressure and hydration to weight, body fat, activity, sleep, and energy.

If my digital scale indicates I’m dehydrated, I’ll likely cut my diuretic dosage in half that day, helping me to avert the inevitable dizziness, neuropathic pain, and continuous glucose monitor (CGM) reading errors that result from dehydration. Later in the day, if I’m better hydrated and my blood pressure goes up as a result, I know to take the rest of that day’s dose. If my resting heart rate goes too high, I might cut back on that day’s caffeine. If my sleep or activity patterns change, it might mean I neglected to take my anemia drug or that it could be time for an iron infusion.

If these data- and life-informed actions don’t right the patterns, I call one of my expert consultants. That can be my endocrinologist, nephrologist, or cardiologist. Armed with the data and an informed sense of what has or hasn’t changed, I can markedly improve my consultation with my physician. Our discussion is far more productive, and it’s that much easier for my doctor to work with me to identify the necessary action.

This is the future of chronic disease management.

A few years ago, I would have said that diabetes patients were different from patients with other conditions — the combined danger of insulin and the development of digital tools put diabetes patients squarely, and uniquely, in charge.

Today, though, many more of our chronic disease–afflicted comrades are following in the path of diabetes patients. The digitally informed patient tribe is growing, as sensors and trackers of various types proliferate. The list of at-home, personal use devices is expanding in ways that are both exciting and daunting. We’re already seeing some promising applications for these new tools and sensors, but it will take patients, physicians, and the health care industry a while to figure out what much of this data output means and, importantly, what actions it might inform.

Diabetes patients have had nearly 35 years of experience of living with data. Yet we’re still learning new and valuable insights, developing a keen sense of what the patterns mean, then circulating our discoveries directly to other patients. These “N of 1” patient-researchers are completely bypassing the standard clinical research process, sharing their findings immediately and helping fellow patients look for solutions. I suspect this trend will be replicated in other disease communities as more patients become immersed in new, emerging data streams. And if diabetes is a guide post, in due time, those “findings” will make their way to clinical researchers who can begin the process of developing a protocol, securing funding, and conducting the studies to see if these personal findings are valid and applicable for a broader patient population.

When I give presentations or sit on panels discussing these issues, a lot of people like to call me an outlier. They say I am unusually engaged and involved in managing my care. I understand their point, but if they’re right, there are a lot of outliers in the type 1 diabetes community. None of us chose this path, but for most of us, the promise that a cure is around the corner has grown stale. We can always hope, but for now we are thankful for the tools and treatments we have that enable us to make data-driven decisions about how to stay alive. Each of us is a living, breathing, N of 1 researcher, a participant, and a clinician. Our physicians are there to help, but decisions about how we care for our own life-long illness is both our responsibility and opportunity.

 

This article originally appeared in NEJM Catalyst on March 10, 2016.

Call for submissions:

Now inviting expert articles, longform articles, and case studies for peer review

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From Patient Engagement
PROMs Usage Is Limited but Growing

Patient Engagement Buzz Survey: PROMs Use Is Growing, but Implementation Takes Effort

While clinical outcomes lend themselves to measurement, quantifying how an individual patient experiences symptoms or a loss of function can be more challenging. One promising approach is the use of Patient-Reported Outcome Measures (PROMs).

Taxonomy of the Patient Voice Table

Taxonomy of the Patient Voice

While health care pursues the important trend of putting patients at the center of care, the terms used to describe this goal are proliferating — and muddying the discourse. This taxonomy attempts to classify some of these terms and make some distinctions.

Agarwal01_pullquote handcrafting the patient experience

Handcrafting the Patient Experience

Health care organizations can take cues from consumer-facing companies like Airbnb to creatively insert convenience and surprise into patient encounters.

Screenshot of Tidepool daily diabetes data

A Taxonomy to Engage Patients: Objectives, Design, and Patient Activation

Health information initiatives will succeed only if they focus on patients’ motivation to engage and reflect the type of engagement they seek.

Ghafur01_pullquote -digital health health care consumer patient experience

Engaging Patients Using Digital Technology — Learning from Other Industries

Providers can benefit patients and disrupt health care by learning from the experience of other industries.

Mission Hospital Virtual Sitter - Drawing of the Virtual Bed Zone and Rails

Reducing Inpatient Falls and Injury Rates by Integrating New Technology with Workflow Redesign

How Mission Hospital scaled a virtual sitter pilot and reduced unassisted falls by 44% and fall-related injuries by 40%.

Health Care Providers Should Incentivize Patients

Survey Snapshot: Patient Financial Incentives — There Are No Quick Fixes

The NEJM Catalyst Insights Council agrees that while financial incentives are a common strategy to engage patients in healthy behaviors, they are not necessarily effective.

Support of Family and Friends Is More Effective Than Clinician Support in Realizing Health Goals - From the Patient Engagement Insights Report: Why No Single Health Incentive Works.

Patient Engagement Survey: Why No Single Health Incentive Works

Initiatives to improve patient engagement come in a variety of forms. While insurers, employers, and health care providers are all involved in using financial incentives and penalties for engagement efforts, improvement in health outcomes has been elusive. Achieving that ultimate goal will usually require a combination of financial and social approaches.

Health Systems Attending the Nudge Units in Health Care Symposium - Penn Medicine

Key Insights on Launching a Nudge Unit within a Health Care System

Leaders are finding that making higher-value choices easier through subtle changes to choice architecture can have an outsized impact on medical decision-making.

Barriers to Providing an Oustanding Patient Experience

Buzz Survey Report: Patient Experience

An independent NEJM Catalyst report sponsored by University of Utah Health on barriers to achieving an excellent patient experience.

Connect

A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

Topics

Patient-Centered Care

282 Articles

Assessing and Addressing Social Needs in…

Lincoln Community Health Center improved care quality by measuring and responding to upstream social and…

Information Asymmetry: The Untapped Value of…

The knowledge and preferences that patients could — and should — share with clinicians would…

Proactively Catching the Declining Patient

A coordinated effort by UCLA leaders to identify a high-cost population with chronic kidney disease…

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now